iiinova — where your digital self keeps evolving

Reposted by Brian Rifkin

Nephrology Journal Club @nephjc.bsky.social · 15h

Can tolvaptan keep up with 3% saline? This within-subject study in healthy volunteers delivered a surprising answer - and a few eyebrow-raising physiology twist. Dive in #NephJC ✍️ by @drsaivani.bsky.social www.nephjc.com/news/tolvapt...

nephjc.com

Raising sodium: can tolvaptan rival 3% hypertonic saline? — NephJC

Testing Tolvaptan versus 3% saline and the rate of rise of serum sodium in healthy volunteers.

076

Reposted by Brian Rifkin

Nephrology Journal Club @nephjc.bsky.social · 30/09/2026

1/10 #NephJC #TenPosts #NephSly 🫘💊 START your steroids! A question we ask constantly but adult RCT data rarely answers after remission in steroid-sensitive MCD/FSGS, how long should the prednisolone taper actually be? 🧵 www.sciencedirect.com/science/arti...

sciencedirect.com

155

Brian Rifkin @brianrifkin.bsky.social · 29/09/2026

So let me get this straight. Trust the science, listen to your physician about your health…unless AI disagrees, and then all bets are off and believe whatever you want.

010

Reposted by Brian Rifkin

Nephrology Journal Club @nephjc.bsky.social · 28/09/2026

Hey #NephJC 👋 Checkout the VA by @divyaveerssneph.bsky.social This week we're looking at steroid weaning strategies in adults with podocytopathies (MCD/FSGS). 💊Steroids: easy to start🟢 but hard to stop 🛑. #NephSky www.nephjc.com/news/starttrial

nephjc.com

START: The Visual Abstract — NephJC

Can steroid tapering be shorter after remission in adults with sensitive podocytopathy?

089

Reposted by Brian Rifkin

Nephrology Journal Club @nephjc.bsky.social · 28/09/2026

El Resumen Visual, gracias @dramiliflores.bsky.social #NephSky #NephJC ¿Cuánto debe durar la reducción gradual de esteroides tras la remisión de una podocitopatía? www.nephjc.com/news/startspanish

nephjc.com

START: El Resumen Visual — NephJC

¿Podemos reducir el uso de esteroides tras la remisión?

031

Reposted by Brian Rifkin

Nephrology Journal Club @nephjc.bsky.social · 28/09/2026

Steroids are useful (and have bad side effects) in patients with podocytopathies. Starting is easy, but stopping can be challenging. Are longer courses of steroids better for longer remissions? How quickly do you taper? 🐇🐢 #NephSky #NephJC www.nephjc.com/news/startsteroidtaper

nephjc.com

Why Can’t I Quit You: Steroid Tapering in Adults with Podocytopathies (START) — NephJC

This week, we will discuss the best schedule for tapering steroids in adult patients with podocytopathies (MCD/FSGS).

076

Reposted by Brian Rifkin

ASN Publications @asnpublications.bsky.social · 17/09/2026

P-CABs may offer a kidney-safe alternative to PPIs for people with CKD. A large study found P-CAB use was associated with a 37% lower risk of kidney replacement therapy initiation compared with PPIs. kidney.pub/KN1809-10 #ASNKidneyNews

032

Reposted by Brian Rifkin

Nephrology Journal Club @nephjc.bsky.social · 15/09/2026

📣Hey #NephSky We just passed 5000 #NephJC Newsletter subscribers Will you be 5001? Also, we can now be found at LinkedIN. So, if you are tired of "the bad place", but don't want to miss the latest, you can follow us there as well! www.nephjc.com/news/nephjc-on-linkedin

nephjc.com

NephJC on LinkedIn — NephJC

NephJC is now more than twelve years old- and it’s amazing to see how far a simple idea has grown. We started with a handful of nephrologists on Twitter (yeah, we still call it that) choosing a paper ...

074

Reposted by Brian Rifkin

Nephrology Journal Club @nephjc.bsky.social · 14/09/2026

⏳ Just a bit over one month until #KidneyWk And yes... the legendary #NephJC party is happening again 🎉 🩵Join us, meet the crew, and meet people from across the world 👇Grab your ticket and come be part of the magic www.nephjc.com/news/2026/9/...

nephjc.com

2026 NephJC Night in Denver — NephJC

On FRIDAY night, October 23rd, NephJC will host another legendary NephJC Night during ASN Kidney Week

042

Reposted by Brian Rifkin

Mayor Zohran Kwame Mamdani @mayor.nyc.gov · 11/09/2026

25 years ago, terrorists killed nearly 3,000 people, including 2,753 New Yorkers. As we remember that terrible day, let us also remember the first responders, office workers and strangers who ran toward danger to help each other.

562328407343

Reposted by Brian Rifkin

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 08/09/2026

It’s that time of the year If you enjoy and like and use #NephJC content, please consider supporting www.nephjc.com/news/2026/9/...

nephjc.com

NephJC 2026 Fall Pledge Drive — NephJC

Help keep NephJC a vital, original, and unbiased source of medical education.

053

Reposted by Brian Rifkin

Nephrology Journal Club @nephjc.bsky.social · 08/09/2026

One week to go until #SummerBookClub As Long as the Lemon Trees Grow by Zoulfa Katouh We will have a live chat! Tuesday 9/15/26 at 9pm EST only on Twitter #NephJC #NephSky 📚There's still time to read it and come discuss

static.klipy.com

Simmering Lemon Slices for Syrup

ALT: Simmering Lemon Slices for Syrup

032

Reposted by Brian Rifkin

Nephrology Journal Club @nephjc.bsky.social · 08/09/2026

#NephJC runs on community magic ✨ We choose to stay free and independent and give back to our community for 12yrs 🩵 If our blogs, podcasts, or visuals have helped you, your donation keeps us going - and might get you into the coolest #KidneyWk party www.nephjc.com/news/2026/9/...

nephjc.com

NephJC 2026 Fall Pledge Drive — NephJC

Help keep NephJC a vital, original, and unbiased source of medical education.

053

Reposted by Brian Rifkin

Nephrology Journal Club @nephjc.bsky.social · 02/09/2026

1/10 #NephJC #TenPostNephJC Validation of an AI model is difficult. 🤖 Enter the REFINe trial (Reasoning Enhancement With Feedback From a Generative AI in Nephrology), a RCT of large language model (LLM) -assisted diagnostic accuracy in nephrology. www.kireports.org/article/S246...

154

Reposted by Brian Rifkin

Nephrology Journal Club @nephjc.bsky.social · 30/08/2026

🤖AI is everywhere 🤖 You will be assimilated! Can the current LLMs help nephrologist diagnose complex nephrology cases? Right out of Sci-Fi movie, it is the REFINe study. VA by @kiddokidney.bsky.social #NephSky #NephJC www.nephjc.com/news/refine-the-visual-abstract

nephjc.com

REFINe: The Visual Abstract — NephJC

Can AI boost clinical decision-making in nephrology?

024

Reposted by Brian Rifkin

Nephrology Journal Club @nephjc.bsky.social · 30/08/2026

El resumen visual de REFINe (acerca de inteligencia artificial) 🤖🦾 @dramiliflores.bsky.social #NephTwitter #NephJC www.nephjc.com/news/refine-el-resumen-visual

nephjc.com

REFINE: El Resumen Visual — NephJC

¿Puede la IA mejorar la toma de decisiones clínicas en nefrología?

123

Brian Rifkin @brianrifkin.bsky.social · 28/08/2026

Hello, this is the nephrology office…we have ANOTHER consult for you 📱

120

Reposted by Brian Rifkin

ASN Publications @asnpublications.bsky.social · 26/08/2026

#ASNJASN study shows that transplant outcomes depend not only on anti-donor antibodies but also on how kidney tissue responds. Molecular signatures of injury and protection could enable more personalized prediction and treatment of antibody-mediated rejection. kidney.pub/JASN1224

031

Reposted by Brian Rifkin

ASN Publications @asnpublications.bsky.social · 26/08/2026

#ASNCJASN launches the Bridging Cardiovascular and Kidney Health Series, spotlighting the powerful heart-kidney connection, transformative CKD therapies, and opportunities to improve prevention, implementation, and patient outcomes. kidney.pub/CJASN1179

011

Reposted by Brian Rifkin

Nephrology Journal Club @nephjc.bsky.social · 26/08/2026

🚨A New #NephJC short 🩳 The first trial in pregnancy and CKD in 30 years - ORCHARD BEET 🌳 Aiming to test feasibility of nitrate administration in pregnant women with CKD by @nephroseeker.medsky.social #NephSky www.nephjc.com/news/orchard-beet

nephjc.com

Dietary nitrate supplementation in CKD pregnancy — NephJC

First trial in pregnancy and CKD after 30 years - aiming to test feasibility of nitrate administration in pregnant women with CKD

052

Reposted by Brian Rifkin

Nephrology Journal Club @nephjc.bsky.social · 25/08/2026

In our Stone Era 🪨 (PUSH/NO STONE) Maybe we don't have a ➕ RCT, but that doesn't exclude usefulness at the patient level 🤷‍♂️. Listen to the experts on the subtleties of stone treatment, don't be a 🥤nihilist. #NephSky www.nephjc.com/freelyfiltered/2026/8/push www.nephjc.com/freelyfiltered/60/nostone

nephjc.com

FF95 The PUSH trial. Push it real good! — NephJC

PUSH Water to prevent kidney stones…or not

131

Reposted by Brian Rifkin

Dr. Smita Divyaveer, MD, DM Nephrology @divyaveerssneph.bsky.social · 21/08/2026

#NephJC takes on MERCURI 2 trial from @JAMA.com It came in hot 🔥 like the planet Mercury.... But does it have the substance to reduce AKI 🫘 👁️👁️Check out the Instagram summary

MERCURI-2 on Instagram — NephJC https://share.google/3BMTrApoBKp8eQUIA

Source: Instagram https://share.google/7hWx03rqR23Eb0RuT

033

Reposted by Brian Rifkin

Nephrology Journal Club @nephjc.bsky.social · 21/08/2026

When our patients start HD, everything gets filtered, except the debate on beta-blocker dialyzability Read #NephJC short about the new target emulation trial, suggesting the non-dialyzables may be doing some heavy MACE-lifting ✍️By @drpallaviprasad.bsky.social nephjc.com/news/targetr...

nephjc.com

Is this the end of the beta-blocker debate in hemodialysis? — NephJC

This week, we will discuss

033

Reposted by Brian Rifkin

Nephrology Journal Club @nephjc.bsky.social · 19/08/2026

1/10 #NephJC #TenPostNephJC #NephSky Can just 4 doses of an SGLT2i prevent AKI after cardiac surgery? The MERCURI-2 trial put dapagliflozin to the test. But is the benefit a treat or a trick?🫀💊 Read the article 👇 pubmed.ncbi.nlm.nih.gov/42530910/

255

Reposted by Brian Rifkin

Nephrology Journal Club @nephjc.bsky.social · 17/08/2026

Excited for SGLT2 inhibitors to prevent AKI in CV surgery patients? So were we... until we got past the title. This week we're talking about "that JAMA paper "🙃 #NephJC #NephSky Here's the VA by @ManoleaA www.nephjc.com/news/2026/8/17/mercuri-the-visual-abstract

nephjc.com

MERCURI-2: The Visual Abstract — NephJC

Does MERCURI-2 challenge how we use SGLT2i in post-operative patients?

175

Reposted by Brian Rifkin

kireports.bsky.social @kireports.bsky.social · 15/08/2026

🧵Skeetorial Alert 🧵 1/ Hey #NephSky! Welcome to a 🆕 #skeetorial brought to you by @kireports.bsky.social

132

Reposted by Brian Rifkin

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 06/08/2026

We love that #NephJc content is reused - that’s the whole purpose of #FOAMEed, learn, teach and pass it forward This was a VA created by Divya Bajpai which was sadly cropped which takes out the logo + creator name That maybe for lack of space - but it’s bad manners - don’t do this! #Medsky

1173

Reposted by Brian Rifkin

Massimo (mirror) @rainmaker1973-m.bsky.social · 05/08/2026

Laundry art [📸 Helga Stentzel] Original post

271874308

Reposted by Brian Rifkin

Nephrology Journal Club @nephjc.bsky.social · 05/08/2026

1/10 #NephJC #TenPostNephJC 💉Bicarbonate is an ICU drug that almost everyone has an opinion on. The physiology is attractive, but evidence isn’t. 🥼SODa-BIC asks if IV bicarbonate improves outcomes in ICU pts with metabolic acidosis on vasopressors. 📄 pubmed.ncbi.nlm.nih.gov/42283370/

142

Reposted by Brian Rifkin

Adam Rawnsley @arawnsley.bsky.social · 04/08/2026

Today, August 4, 2026, is the setting of Ray Bradbury’s short story “There Will Come Soft Rains” about a fully automated house continuing on after the family who lived there and the world around it died in a nuclear blast.

10346191519

Reposted by Brian Rifkin

Nephrology Journal Club @nephjc.bsky.social · 03/08/2026

🖌️Check out the #visualabstract for the SODa-BIC trial by @danyrcal.bsky.social #NephJC www.nephjc.com/news/2026/8/...

165

Reposted by Brian Rifkin

Nephrology Journal Club @nephjc.bsky.social · 03/08/2026

🖌️ Echa un vistazo al #resumenvisual del ensayo SODa‑BIC realizado por @danyrcal.bsky.social #NephJC www.nephjc.com/news/2026/8/...

043

Reposted by Brian Rifkin

Nephrology Journal Club @nephjc.bsky.social · 31/07/2026

Summer's almost over 😎 #NephSky We know you've been waiting 🏖️ #NephJC Summer Book Club, 9/15/26 discussion! Salama Kassab was a pharmacy student in Syria. Now she helps the wounded who flood through the doors. Set amid the Syrian Revolution, a story of hope, love & possibility.

066

Reposted by Brian Rifkin

ASN Publications @asnpublications.bsky.social · 22/07/2026

#ASNJASN: >50% of ESRD beneficiaries are now in Medicare Advantage, yet only 1 Star measure assesses kidney care. Major gaps remain in CKD screening, nephrology referral, kidney-protective therapies, and transplant referral. kidney.pub/JASN1200?... @asnkidney.bsky.social @cervantes-lily1.bsky.social

033

Reposted by Brian Rifkin

Nephrology Journal Club @nephjc.bsky.social · 22/07/2026

#NephJC #TenPostNephJC FIND-CKD asks: Can we extend nsMRA cardiorenal benefits to the massive population with CKD without diabetes? Let’s FIND out! 🔍 Read the article 👇: pubmed.ncbi.nlm.nih.gov/42246672/ 1/10🧵

1115

Reposted by Brian Rifkin

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 20/07/2026

a young teenager with hypertension, case studies from @nejm.org enough info in table 1 to make a diagnosis! www.nejm.org/doi/full/10....

lab values showing
hypokalemia
elevated ESR/CRP

373

Reposted by Brian Rifkin

Nephrology Journal Club @nephjc.bsky.social · 21/07/2026

Want more?? #NephSky #NephJC 🩳FIND-CKD shorts from @CristinaDeReins Finerenone in glomerulonephritis & a pooled analysis of safety and efficacy in CKD (INFINITY) www.nephjc.com/news/2026/7/20/finerenone-shorts

nephjc.com

Finerenone across the proteinuric CKD spectrum — NephJC

Cristina Popa dissects the FIND-CKD extras: GN subgroup and INFINITY analysis

077